Condensed Consolidated Statements of Operations (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue, net:
Core companion animal health	$ 16,371	$ 14,515	$ 51,223	$ 46,015
Other vaccines, pharmaceuticals and products	5,434	3,080	14,291	8,820
Total revenue, net	21,805	17,595	65,514	54,835
Cost of revenue	13,488	10,189	39,841	34,607
Gross profit	8,317	7,406	25,673	20,228
Operating expenses:
Selling and marketing	4,716	4,591	14,413	14,554
Research and development	322	324	1,084	1,197
General and administrative	2,938	2,416	9,019	8,662
Total operating expenses	7,976	7,331	24,516	24,413
Operating income (loss)	341	75	1,157	(4,185)
Interest and other (income) expense, net	(40)	93	(31)	134
Income (loss) before income taxes	381	(18)	1,188	(4,319)
Current tax expense	60	6	113	71
Deferred tax expense (benefit)	306	(6)	555	(1,553)
Total income tax expense (benefit)	366	0	668	(1,482)
Net income (loss)	15	(18)	520	(2,837)
Net income (loss) attributable to non-controlling interest	(498)	(259)	(1,254)	(464)
Net income (loss) attributable to Heska Corporation	$ 513	$ 241	$ 1,774	$ (2,373)
Basic net income (loss) per share attributable to Heska Corporation	$ 0.09	$ 0.04	$ 0.30	$ (0.41)
Diluted net income (loss) per share attributable to Heska Corporation	$ 0.08	$ 0.04	$ 0.28	$ (0.41)
Weighted average outstanding shares used to compute basic net income (loss) per share attributable to Heska Corp.	5,989	5,826	5,929	5,727
Weighted average outstanding shares used to compute diluted net income (loss) per share attributable to Heska Corp	6,554	5,865	6,314	5,727